Menu
Back to User profile » Dr Weijun Peng
Papers published by Dr Weijun Peng:
Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis
Tang M, Zeng Y, Peng W, Xie X, Yang Y, Ji B, Li F
Drug Design, Development and Therapy 2022, 16:2043-2053
Published Date: 29 June 2022
Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, Wang Y, Zhang B, Li W
Drug Design, Development and Therapy 2021, 15:3255-3276
Published Date: 28 July 2021
Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer
Huang S, Zhang Z, Li W, Kong F, Yi P, Huang J, Mao D, Peng W, Zhang S
Drug Design, Development and Therapy 2020, 14:2725-2740
Published Date: 14 July 2020
A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum]
He D, Huang JH, Zhang ZY, Du Q, Peng WJ, Yu R, Zhang SF, Zhang SH, Qin YH
Drug Design, Development and Therapy 2020, 14:949-950
Published Date: 2 March 2020
A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus
He D, Huang JH, Zhang ZY, Du Q, Peng WJ, Yu R, Zhang SF, Zhang SH, Qin YH
Drug Design, Development and Therapy 2019, 13:3989-4005
Published Date: 28 November 2019
Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis
Yang S, Xing ZH, Liu T, Zhou J, Liang QH, Tang T, Cui HJ, Peng WJ, Xiong XG, Wang Y
Drug Design, Development and Therapy 2018, 12:463-473
Published Date: 6 March 2018